Summit Global Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,145
Closed -$849K 462
2025
Q1
$849K Buy
+3,145
New +$849K 0.06% 192